Implementation of Coordinated Global Serotype 2 Oral Poliovirus Vaccine Cessation: Risks of Potential Non-Synchronous Cessation

BMC Infectious Diseases- United Kingdom

doi 10.1186/s12879-016-1536-9

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC


Related search